XILIO THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
XLO
CUSIP
98422T209
Type
Equity
Class
COM
Num filings
26
Total reported value, excl. options
$26.4 M
Compare 2026 Q2 to
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type